(Q33491284)

27 July 2017

Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity (English)

1 reference

27 July 2017

1 reference

Pierre P Major

1

1 reference

27 July 2017

Richard J Cook

2

1 reference

27 July 2017

Allan Lipton

3

1 reference

27 July 2017

Matthew R Smith

4

1 reference

27 July 2017

Evangelos Terpos

5

1 reference

27 July 2017

Robert E Coleman

6

1 reference

27 July 2017

language of work or name

English

0 references

publication date

6 August 2009

1 reference

27 July 2017

1 reference

27 July 2017

9

1 reference

27 July 2017

272

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

start time

6 August 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-272

0 references

cites work

Bisphosphonates: reducing the risk of skeletal complications from bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739221

21 June 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739221

Clinical features of metastatic bone disease and risk of skeletal morbidity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739221

Bone resorption predicts for skeletal complications in metastatic bone disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739221

Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739221

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739221

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Marginal analysis of recurrent events and a terminating event.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Survival-adjusted multiple-event analysis for the evaluation of treatment effects of zoledronic Acid in patients with bone metastases from solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-272

Methodology for treatment evaluation in patients with cancer metastatic to bone

21 January 2018

1 reference

12 December 2020

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

12 December 2020

Pathologic fractures correlate with reduced survival in patients with malignant bone disease

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-272

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference